Drugbank Logo

Search Results

Search for "Cefonicid" returned 6 results

Showing 1-6 out of 6
DrugBank ID Name Formula Weight
DB01328
DrugCard button for DB01328
Cefonicid C18H18N6O8S3 542.5660
Cefonicid Cefonicid is a second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for ...
DB00479
DrugCard button for DB00479
Amikacin C22H43N5O13 585.6025
... of nephrotoxicity Cefazolin Increased risk of nephrotoxicity Cefonicid Increased risk of nephrotoxicity Cefoperazone Increased risk of nephrotoxicity Ceforanide Increased risk of ...
DB01032
DrugCard button for DB01032
Probenecid C13H19NO4S 285.3590
... level Cefmetazole Probenecid increases the antibiotic's level Cefonicid Probenecid increases the antibiotic's level Cefotaxime Probenecid increases the antibiotic's level Cefotetan Probenecid ...
DB00798
DrugCard button for DB00798
Gentamicin C21H43N5O7 477.5954
... of nephrotoxicity Cefazolin Increased risk of nephrotoxicity Cefonicid Increased risk of nephrotoxicity Cefoperazone Increased risk of nephrotoxicity Ceforanide Increased risk of ...
DB00955
DrugCard button for DB00955
Netilmicin C21H41N5O7 475.5795
... of nephrotoxicity Cefazolin Increased risk of nephrotoxicity Cefonicid Increased risk of nephrotoxicity Cefoperazone Increased risk of nephrotoxicity Ceforanide Increased risk of ...
DB00684
DrugCard button for DB00684
Tobramycin C18H37N5O9 467.5145
... of nephrotoxicity Cefazolin Increased risk of nephrotoxicity Cefonicid Increased risk of nephrotoxicity Cefoperazone Increased risk of nephrotoxicity Ceforanide Increased risk of ...
Showing 1-6 out of 6

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.